

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.44377296 |
| 2 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.10244924 |
| 3 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.04441646 |
| 4 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.04441646 |
| 5 | positive regulation of B cell differentiation (GO:0045579) | 4.95771983 |
| 6 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.81602819 |
| 7 | response to peptidoglycan (GO:0032494) | 4.78351996 |
| 8 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.57105944 |
| 9 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.50379067 |
| 10 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.32353901 |
| 11 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.32044404 |
| 12 | B cell receptor signaling pathway (GO:0050853) | 4.28620014 |
| 13 | regulation of B cell differentiation (GO:0045577) | 4.15790953 |
| 14 | regulation of gamma-delta T cell activation (GO:0046643) | 3.94279553 |
| 15 | positive regulation by symbiont of host defense response (GO:0052509) | 3.78469602 |
| 16 | modulation by symbiont of host defense response (GO:0052031) | 3.78469602 |
| 17 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.78469602 |
| 18 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.78469602 |
| 19 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.78469602 |
| 20 | modulation by symbiont of host immune response (GO:0052553) | 3.78469602 |
| 21 | positive thymic T cell selection (GO:0045059) | 3.71893101 |
| 22 | negative regulation of granulocyte differentiation (GO:0030853) | 3.69964695 |
| 23 | detection of molecule of bacterial origin (GO:0032490) | 3.56517662 |
| 24 | detection of other organism (GO:0098543) | 3.55203731 |
| 25 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.49905203 |
| 26 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.49381204 |
| 27 | NIK/NF-kappaB signaling (GO:0038061) | 3.44720899 |
| 28 | immunoglobulin mediated immune response (GO:0016064) | 3.43568114 |
| 29 | macrophage activation involved in immune response (GO:0002281) | 3.42746690 |
| 30 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.38636884 |
| 31 | negative regulation of phagocytosis (GO:0050765) | 3.36473323 |
| 32 | positive regulation of interferon-alpha production (GO:0032727) | 3.35552889 |
| 33 | regulation of mast cell degranulation (GO:0043304) | 3.33021912 |
| 34 | endothelial tube morphogenesis (GO:0061154) | 3.23550121 |
| 35 | morphogenesis of an endothelium (GO:0003159) | 3.23550121 |
| 36 | detection of bacterium (GO:0016045) | 3.23026632 |
| 37 | detection of external biotic stimulus (GO:0098581) | 3.21659066 |
| 38 | positive regulation of mast cell activation (GO:0033005) | 3.17797937 |
| 39 | regulation of interferon-alpha production (GO:0032647) | 3.15156820 |
| 40 | myeloid cell activation involved in immune response (GO:0002275) | 3.06203510 |
| 41 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.06017132 |
| 42 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.05398792 |
| 43 | response to host immune response (GO:0052572) | 3.04413051 |
| 44 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.04413051 |
| 45 | positive regulation of histone deacetylation (GO:0031065) | 3.04145201 |
| 46 | detection of biotic stimulus (GO:0009595) | 3.02510436 |
| 47 | mature B cell differentiation (GO:0002335) | 3.01390245 |
| 48 | regulation of leukocyte degranulation (GO:0043300) | 3.01257755 |
| 49 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.00631230 |
| 50 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.99955614 |
| 51 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.99141223 |
| 52 | response to host (GO:0075136) | 2.98237410 |
| 53 | response to host defenses (GO:0052200) | 2.98237410 |
| 54 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.98237410 |
| 55 | cellular extravasation (GO:0045123) | 2.97872612 |
| 56 | natural killer cell differentiation (GO:0001779) | 2.96727389 |
| 57 | negative regulation of cell killing (GO:0031342) | 2.96272786 |
| 58 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.96272786 |
| 59 | myeloid dendritic cell differentiation (GO:0043011) | 2.94838170 |
| 60 | regulation of mast cell activation (GO:0033003) | 2.92837515 |
| 61 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.92641417 |
| 62 | pinocytosis (GO:0006907) | 2.89771624 |
| 63 | microglial cell activation (GO:0001774) | 2.88441960 |
| 64 | cellular response to zinc ion (GO:0071294) | 2.87658085 |
| 65 | granulocyte activation (GO:0036230) | 2.87536612 |
| 66 | myeloid dendritic cell activation (GO:0001773) | 2.86657128 |
| 67 | negative regulation of interleukin-12 production (GO:0032695) | 2.86431415 |
| 68 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.86293544 |
| 69 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.85783841 |
| 70 | response to laminar fluid shear stress (GO:0034616) | 2.85546465 |
| 71 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.84504694 |
| 72 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.84262520 |
| 73 | tolerance induction (GO:0002507) | 2.81988970 |
| 74 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.81666572 |
| 75 | mannose metabolic process (GO:0006013) | 2.80447687 |
| 76 | positive regulation of antigen processing and presentation (GO:0002579) | 2.78486347 |
| 77 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.76424970 |
| 78 | positive regulation of mast cell degranulation (GO:0043306) | 2.76424970 |
| 79 | protein localization to endosome (GO:0036010) | 2.75209426 |
| 80 | negative regulation of B cell proliferation (GO:0030889) | 2.74371914 |
| 81 | neutrophil activation involved in immune response (GO:0002283) | 2.69897195 |
| 82 | positive regulation of isotype switching (GO:0045830) | 2.69841816 |
| 83 | I-kappaB phosphorylation (GO:0007252) | 2.69322505 |
| 84 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.68953225 |
| 85 | regulation of tolerance induction (GO:0002643) | 2.68010562 |
| 86 | response to muramyl dipeptide (GO:0032495) | 2.67479351 |
| 87 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.66870179 |
| 88 | positive regulation of macrophage cytokine production (GO:0060907) | 2.66154078 |
| 89 | regulation of platelet aggregation (GO:0090330) | 2.64333228 |
| 90 | defense response to protozoan (GO:0042832) | 2.62066000 |
| 91 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.61231631 |
| 92 | regulation of T cell tolerance induction (GO:0002664) | 2.60579398 |
| 93 | thymic T cell selection (GO:0045061) | 2.60294977 |
| 94 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.59748537 |
| 95 | negative regulation of interleukin-6 production (GO:0032715) | 2.59445552 |
| 96 | positive regulation of leukocyte degranulation (GO:0043302) | 2.58805505 |
| 97 | regulation of antigen processing and presentation (GO:0002577) | 2.58535761 |
| 98 | germinal center formation (GO:0002467) | 2.57061403 |
| 99 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.56926754 |
| 100 | regulation of interleukin-17 production (GO:0032660) | 2.56734520 |
| 101 | mature B cell differentiation involved in immune response (GO:0002313) | 2.56586442 |
| 102 | angiogenesis involved in wound healing (GO:0060055) | 2.56493743 |
| 103 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.56246169 |
| 104 | positive regulation of interferon-beta production (GO:0032728) | 2.56120326 |
| 105 | positive regulation of macrophage differentiation (GO:0045651) | 2.55819971 |
| 106 | B cell homeostasis (GO:0001782) | 2.55212156 |
| 107 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.54442443 |
| 108 | T cell migration (GO:0072678) | 2.54069315 |
| 109 | B cell mediated immunity (GO:0019724) | 2.53866495 |
| 110 | dendritic cell differentiation (GO:0097028) | 2.53625085 |
| 111 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.53585448 |
| 112 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.53466211 |
| 113 | response to protozoan (GO:0001562) | 2.52989017 |
| 114 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.52816937 |
| 115 | lymphocyte homeostasis (GO:0002260) | 2.51877956 |
| 116 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.51863174 |
| 117 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.51628471 |
| 118 | germ cell migration (GO:0008354) | 2.51508709 |
| 119 | myeloid leukocyte activation (GO:0002274) | 2.51118753 |
| 120 | positive regulation of protein deacetylation (GO:0090312) | 2.50812121 |
| 121 | negative thymic T cell selection (GO:0045060) | 2.50591692 |
| 122 | T-helper 1 type immune response (GO:0042088) | 2.50543679 |
| 123 | T cell homeostasis (GO:0043029) | 2.49458510 |
| 124 | negative regulation of bone resorption (GO:0045779) | 2.48591783 |
| 125 | regulation of B cell proliferation (GO:0030888) | 2.48558576 |
| 126 | response to interleukin-15 (GO:0070672) | 2.47993961 |
| 127 | positive regulation of interleukin-17 production (GO:0032740) | 2.47370760 |
| 128 | neutrophil mediated immunity (GO:0002446) | 2.46811892 |
| 129 | positive regulation of B cell activation (GO:0050871) | 2.46605908 |
| 130 | lymph node development (GO:0048535) | 2.46138470 |
| 131 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.44661697 |
| 132 | macrophage activation (GO:0042116) | 2.43951455 |
| 133 | leukocyte aggregation (GO:0070486) | 2.43008445 |
| 134 | B cell proliferation (GO:0042100) | 2.42077475 |
| 135 | growth hormone receptor signaling pathway (GO:0060396) | 2.39950443 |
| 136 | positive regulation of lamellipodium assembly (GO:0010592) | 2.39062179 |
| 137 | regulation of macrophage cytokine production (GO:0010935) | 2.37364895 |
| 138 | regulation of necroptotic process (GO:0060544) | 2.37143852 |
| 139 | regulation of granulocyte differentiation (GO:0030852) | 2.37021636 |
| 140 | respiratory burst (GO:0045730) | 2.36810340 |
| 141 | regulation of B cell apoptotic process (GO:0002902) | 2.35450306 |
| 142 | regulation of interleukin-12 production (GO:0032655) | 2.35154992 |
| 143 | regulation of response to interferon-gamma (GO:0060330) | 2.34858441 |
| 144 | positive regulation of cell adhesion mediated by integrin (GO:0033630) | 2.34824115 |
| 145 | neutrophil activation (GO:0042119) | 2.33490595 |
| 146 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.33392456 |
| 147 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.32101731 |
| 148 | negative T cell selection (GO:0043383) | 2.31272675 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.33228106 |
| 2 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.64947795 |
| 3 | MYC_22102868_ChIP-Seq_BL_Human | 3.38587967 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.24234817 |
| 5 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.18504886 |
| 6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.11543339 |
| 7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.03085416 |
| 8 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.91393212 |
| 9 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.90937195 |
| 10 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.86986456 |
| 11 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.70951297 |
| 12 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.62502368 |
| 13 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.57752551 |
| 14 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.56641318 |
| 15 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.55639840 |
| 16 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.50694904 |
| 17 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.42158284 |
| 18 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.34498094 |
| 19 | * MAF_26560356_Chip-Seq_TH1_Human | 2.33568565 |
| 20 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.31426650 |
| 21 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.23532064 |
| 22 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.17811399 |
| 23 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.17070945 |
| 24 | * VDR_24763502_ChIP-Seq_THP-1_Human | 2.11228523 |
| 25 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.10640853 |
| 26 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.08050010 |
| 27 | * MYB_26560356_Chip-Seq_TH2_Human | 2.04408018 |
| 28 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.03824241 |
| 29 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.03511083 |
| 30 | UTX_26944678_Chip-Seq_JUKART_Human | 2.01966498 |
| 31 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.01234950 |
| 32 | * MYB_26560356_Chip-Seq_TH1_Human | 1.99166874 |
| 33 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.98287864 |
| 34 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.97868016 |
| 35 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.97818104 |
| 36 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.96227000 |
| 37 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.91047520 |
| 38 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.89652042 |
| 39 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.89580339 |
| 40 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.89341610 |
| 41 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.88388574 |
| 42 | SPI1_23127762_ChIP-Seq_K562_Human | 1.86310269 |
| 43 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.78981915 |
| 44 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.78968989 |
| 45 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.77051505 |
| 46 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.75906687 |
| 47 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.72185019 |
| 48 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.62548835 |
| 49 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.59444084 |
| 50 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47766741 |
| 51 | MAF_26560356_Chip-Seq_TH2_Human | 1.46362709 |
| 52 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.45643178 |
| 53 | GATA1_22025678_ChIP-Seq_K562_Human | 1.44386751 |
| 54 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.41961224 |
| 55 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.40933357 |
| 56 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.39835217 |
| 57 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37908130 |
| 58 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.37836512 |
| 59 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.37199614 |
| 60 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.35116441 |
| 61 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35078614 |
| 62 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.33763150 |
| 63 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.31420007 |
| 64 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.30014972 |
| 65 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.27475419 |
| 66 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.26410131 |
| 67 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25400166 |
| 68 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.24874254 |
| 69 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.21112554 |
| 70 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.19358673 |
| 71 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.18859431 |
| 72 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.17579130 |
| 73 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.16612736 |
| 74 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.16255599 |
| 75 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.14578824 |
| 76 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.14511141 |
| 77 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.13200081 |
| 78 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.10616785 |
| 79 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.09164907 |
| 80 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.07842075 |
| 81 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.06129291 |
| 82 | * TFEB_21752829_ChIP-Seq_HELA_Human | 1.05970961 |
| 83 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.05573537 |
| 84 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.05342913 |
| 85 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04822196 |
| 86 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.04715261 |
| 87 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.03652480 |
| 88 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.02261244 |
| 89 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.00423939 |
| 90 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.99847119 |
| 91 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.95565555 |
| 92 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95421750 |
| 93 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.95233704 |
| 94 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.95144544 |
| 95 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.94735252 |
| 96 | * GATA1_19941826_ChIP-Seq_K562_Human | 0.94052459 |
| 97 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.93635993 |
| 98 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.93128594 |
| 99 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.92701843 |
| 100 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92380209 |
| 101 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.91886018 |
| 102 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.90168680 |
| 103 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88763220 |
| 104 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.88596449 |
| 105 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.88596449 |
| 106 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.88527115 |
| 107 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.87651959 |
| 108 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.86990746 |
| 109 | * GATA3_26560356_Chip-Seq_TH2_Human | 0.86821221 |
| 110 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.86746959 |
| 111 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.85322073 |
| 112 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.84895330 |
| 113 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.83312846 |
| 114 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.83127224 |
| 115 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.82492221 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.72568466 |
| 2 | MP0003303_peritoneal_inflammation | 3.17843772 |
| 3 | MP0000685_abnormal_immune_system | 2.96131955 |
| 4 | MP0001790_abnormal_immune_system | 2.74468645 |
| 5 | MP0005387_immune_system_phenotype | 2.74468645 |
| 6 | MP0001800_abnormal_humoral_immune | 2.74244477 |
| 7 | MP0003300_gastrointestinal_ulcer | 2.57770762 |
| 8 | MP0003436_decreased_susceptibility_to | 2.53608263 |
| 9 | MP0002452_abnormal_antigen_presenting | 2.41023369 |
| 10 | MP0004510_myositis | 2.30096122 |
| 11 | MP0009278_abnormal_bone_marrow | 2.27006586 |
| 12 | MP0005000_abnormal_immune_tolerance | 2.23105943 |
| 13 | MP0002723_abnormal_immune_serum | 2.14415470 |
| 14 | MP0002419_abnormal_innate_immunity | 2.06438915 |
| 15 | MP0002420_abnormal_adaptive_immunity | 2.04613055 |
| 16 | MP0002396_abnormal_hematopoietic_system | 2.04154011 |
| 17 | MP0001819_abnormal_immune_cell | 2.02446813 |
| 18 | MP0005671_abnormal_response_to | 2.01688937 |
| 19 | MP0002166_altered_tumor_susceptibility | 1.95967394 |
| 20 | MP0005025_abnormal_response_to | 1.93344107 |
| 21 | * MP0002398_abnormal_bone_marrow | 1.92432171 |
| 22 | MP0005464_abnormal_platelet_physiology | 1.88037565 |
| 23 | MP0003191_abnormal_cellular_cholesterol | 1.85572394 |
| 24 | MP0002405_respiratory_system_inflammati | 1.81720354 |
| 25 | * MP0004808_abnormal_hematopoietic_stem | 1.80851847 |
| 26 | MP0009785_altered_susceptibility_to | 1.80454250 |
| 27 | MP0009840_abnormal_foam_cell | 1.80197556 |
| 28 | MP0010368_abnormal_lymphatic_system | 1.78593315 |
| 29 | * MP0000716_abnormal_immune_system | 1.75571202 |
| 30 | * MP0000689_abnormal_spleen_morphology | 1.74635570 |
| 31 | MP0005058_abnormal_lysosome_morphology | 1.68659039 |
| 32 | MP0001873_stomach_inflammation | 1.68087224 |
| 33 | MP0001853_heart_inflammation | 1.67590462 |
| 34 | MP0000465_gastrointestinal_hemorrhage | 1.66613801 |
| 35 | MP0005451_abnormal_body_composition | 1.65738009 |
| 36 | MP0001545_abnormal_hematopoietic_system | 1.65322898 |
| 37 | MP0005397_hematopoietic_system_phenotyp | 1.65322898 |
| 38 | MP0006082_CNS_inflammation | 1.62790115 |
| 39 | MP0002148_abnormal_hypersensitivity_rea | 1.62429113 |
| 40 | MP0003705_abnormal_hypodermis_morpholog | 1.58753559 |
| 41 | * MP0002722_abnormal_immune_system | 1.57941873 |
| 42 | MP0003763_abnormal_thymus_physiology | 1.56025585 |
| 43 | MP0003828_pulmonary_edema | 1.55277158 |
| 44 | MP0009333_abnormal_splenocyte_physiolog | 1.54733917 |
| 45 | MP0002138_abnormal_hepatobiliary_system | 1.53824603 |
| 46 | * MP0002429_abnormal_blood_cell | 1.51508936 |
| 47 | MP0001879_abnormal_lymphatic_vessel | 1.50702647 |
| 48 | MP0003566_abnormal_cell_adhesion | 1.44968913 |
| 49 | MP0001845_abnormal_inflammatory_respons | 1.44520273 |
| 50 | MP0010155_abnormal_intestine_physiology | 1.43464656 |
| 51 | MP0004947_skin_inflammation | 1.43438243 |
| 52 | MP0003279_aneurysm | 1.39787516 |
| 53 | MP0008260_abnormal_autophagy | 1.37530211 |
| 54 | MP0003172_abnormal_lysosome_physiology | 1.35945381 |
| 55 | MP0008004_abnormal_stomach_pH | 1.35008057 |
| 56 | MP0001533_abnormal_skeleton_physiology | 1.33876436 |
| 57 | MP0010352_gastrointestinal_tract_polyps | 1.32584575 |
| 58 | MP0003656_abnormal_erythrocyte_physiolo | 1.31135537 |
| 59 | MP0010307_abnormal_tumor_latency | 1.30779225 |
| 60 | MP0002006_tumorigenesis | 1.26149954 |
| 61 | MP0000703_abnormal_thymus_morphology | 1.24788394 |
| 62 | MP0003724_increased_susceptibility_to | 1.24737658 |
| 63 | MP0005164_abnormal_response_to | 1.23264006 |
| 64 | MP0005076_abnormal_cell_differentiation | 1.18484363 |
| 65 | MP0000767_abnormal_smooth_muscle | 1.17133712 |
| 66 | MP0008469_abnormal_protein_level | 1.14775135 |
| 67 | MP0002933_joint_inflammation | 1.13279688 |
| 68 | MP0000343_altered_response_to | 1.11220531 |
| 69 | MP0000604_amyloidosis | 1.08118648 |
| 70 | MP0003448_altered_tumor_morphology | 1.05366382 |
| 71 | MP0000249_abnormal_blood_vessel | 1.03512606 |
| 72 | MP0005174_abnormal_tail_pigmentation | 1.01403179 |
| 73 | MP0003866_abnormal_defecation | 1.01008070 |
| 74 | MP0003950_abnormal_plasma_membrane | 0.98844845 |
| 75 | MP0005023_abnormal_wound_healing | 0.98203457 |
| 76 | MP0005390_skeleton_phenotype | 0.96393665 |
| 77 | MP0003091_abnormal_cell_migration | 0.96197137 |
| 78 | MP0005310_abnormal_salivary_gland | 0.94381307 |
| 79 | MP0008438_abnormal_cutaneous_collagen | 0.93758315 |
| 80 | MP0000858_altered_metastatic_potential | 0.92832956 |
| 81 | MP0000733_abnormal_muscle_development | 0.92660548 |
| 82 | MP0005165_increased_susceptibility_to | 0.92633318 |
| 83 | MP0000490_abnormal_crypts_of | 0.92582453 |
| 84 | MP0000569_abnormal_digit_pigmentation | 0.91556306 |
| 85 | MP0010630_abnormal_cardiac_muscle | 0.89936751 |
| 86 | MP0005670_abnormal_white_adipose | 0.88181913 |
| 87 | MP0002332_abnormal_exercise_endurance | 0.85326329 |
| 88 | MP0001851_eye_inflammation | 0.85290749 |
| 89 | MP0004130_abnormal_muscle_cell | 0.84410211 |
| 90 | MP0005167_abnormal_blood-brain_barrier | 0.84328331 |
| 91 | MP0006054_spinal_hemorrhage | 0.83997889 |
| 92 | MP0000609_abnormal_liver_physiology | 0.83086633 |
| 93 | MP0002998_abnormal_bone_remodeling | 0.81707786 |
| 94 | MP0000015_abnormal_ear_pigmentation | 0.81303151 |
| 95 | MP0003795_abnormal_bone_structure | 0.80938130 |
| 96 | MP0008961_abnormal_basal_metabolism | 0.80547641 |
| 97 | MP0001663_abnormal_digestive_system | 0.80054345 |
| 98 | MP0001915_intracranial_hemorrhage | 0.79888473 |
| 99 | MP0003183_abnormal_peptide_metabolism | 0.79856386 |
| 100 | MP0004084_abnormal_cardiac_muscle | 0.79272913 |
| 101 | MP0002019_abnormal_tumor_incidence | 0.78839662 |
| 102 | MP0002928_abnormal_bile_duct | 0.76317629 |
| 103 | MP0003453_abnormal_keratinocyte_physiol | 0.75873377 |
| 104 | MP0001958_emphysema | 0.74197849 |
| 105 | MP0009764_decreased_sensitivity_to | 0.74011299 |
| 106 | MP0000598_abnormal_liver_morphology | 0.73694098 |
| 107 | MP0003075_altered_response_to | 0.71393950 |
| 108 | MP0002877_abnormal_melanocyte_morpholog | 0.71208867 |
| 109 | MP0003690_abnormal_glial_cell | 0.70608074 |
| 110 | MP0002136_abnormal_kidney_physiology | 0.70571645 |
| 111 | MP0001542_abnormal_bone_strength | 0.70522487 |
| 112 | MP0005166_decreased_susceptibility_to | 0.70369862 |
| 113 | MP0002132_abnormal_respiratory_system | 0.68091763 |
| 114 | MP0002128_abnormal_blood_circulation | 0.67057618 |
| 115 | MP0009763_increased_sensitivity_to | 0.64367563 |
| 116 | MP0000371_diluted_coat_color | 0.63518777 |
| 117 | MP0004883_abnormal_blood_vessel | 0.62454202 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Colitis (HP:0002583) | 4.27748859 |
| 2 | Cellulitis (HP:0100658) | 4.08529224 |
| 3 | Agammaglobulinemia (HP:0004432) | 4.08463181 |
| 4 | Recurrent abscess formation (HP:0002722) | 4.06981854 |
| 5 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.97972863 |
| 6 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.97972863 |
| 7 | Abnormality of glycolipid metabolism (HP:0010969) | 3.97972863 |
| 8 | Eczematoid dermatitis (HP:0000976) | 3.93914192 |
| 9 | Inflammation of the large intestine (HP:0002037) | 3.85080460 |
| 10 | Gastrointestinal inflammation (HP:0004386) | 3.79276415 |
| 11 | Recurrent bacterial skin infections (HP:0005406) | 3.74385077 |
| 12 | Abnormality of the nasal mucosa (HP:0000433) | 3.66729315 |
| 13 | Hematochezia (HP:0002573) | 3.66467245 |
| 14 | Recurrent viral infections (HP:0004429) | 3.65554719 |
| 15 | Recurrent bronchitis (HP:0002837) | 3.49845764 |
| 16 | Nasal polyposis (HP:0100582) | 3.42122985 |
| 17 | Spontaneous hematomas (HP:0007420) | 3.41391126 |
| 18 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.38741673 |
| 19 | Stomatitis (HP:0010280) | 3.33202630 |
| 20 | Chronic otitis media (HP:0000389) | 3.30453849 |
| 21 | Cerebral aneurysm (HP:0004944) | 3.22991383 |
| 22 | Recurrent fungal infections (HP:0002841) | 3.22393174 |
| 23 | Systemic lupus erythematosus (HP:0002725) | 3.21345893 |
| 24 | Myositis (HP:0100614) | 3.18885497 |
| 25 | IgM deficiency (HP:0002850) | 3.14625940 |
| 26 | Panhypogammaglobulinemia (HP:0003139) | 3.09792261 |
| 27 | Gastrointestinal stroma tumor (HP:0100723) | 3.02182015 |
| 28 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.01329126 |
| 29 | Papilloma (HP:0012740) | 2.94418205 |
| 30 | Verrucae (HP:0200043) | 2.94418205 |
| 31 | Meningitis (HP:0001287) | 2.93748895 |
| 32 | Petechiae (HP:0000967) | 2.79129391 |
| 33 | Amyloidosis (HP:0011034) | 2.77163715 |
| 34 | Autoimmune thrombocytopenia (HP:0001973) | 2.73202913 |
| 35 | Osteomyelitis (HP:0002754) | 2.67766933 |
| 36 | Mediastinal lymphadenopathy (HP:0100721) | 2.66264171 |
| 37 | Recurrent skin infections (HP:0001581) | 2.64647882 |
| 38 | Aortic aneurysm (HP:0004942) | 2.63213092 |
| 39 | Vasculitis (HP:0002633) | 2.62976111 |
| 40 | Emphysema (HP:0002097) | 2.61104441 |
| 41 | Orchitis (HP:0100796) | 2.57164498 |
| 42 | Abnormality of the fingertips (HP:0001211) | 2.56515359 |
| 43 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.55833593 |
| 44 | Hemoptysis (HP:0002105) | 2.50169117 |
| 45 | Glomerulonephritis (HP:0000099) | 2.50037787 |
| 46 | Interstitial pulmonary disease (HP:0006530) | 2.44032040 |
| 47 | Abnormal platelet volume (HP:0011876) | 2.42910037 |
| 48 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.42229159 |
| 49 | Recurrent cutaneous fungal infections (HP:0011370) | 2.42229159 |
| 50 | Recurrent sinusitis (HP:0011108) | 2.39715689 |
| 51 | Increased density of long bones (HP:0006392) | 2.39442189 |
| 52 | Purpura (HP:0000979) | 2.38799608 |
| 53 | Pustule (HP:0200039) | 2.35202261 |
| 54 | Vacuolated lymphocytes (HP:0001922) | 2.34969658 |
| 55 | * Myocardial infarction (HP:0001658) | 2.34940801 |
| 56 | Urticaria (HP:0001025) | 2.33105336 |
| 57 | T lymphocytopenia (HP:0005403) | 2.30038681 |
| 58 | Abnormality of T cell physiology (HP:0011840) | 2.29877410 |
| 59 | Prolonged bleeding time (HP:0003010) | 2.28825926 |
| 60 | Increased cerebral lipofuscin (HP:0011813) | 2.28483446 |
| 61 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.27910368 |
| 62 | Osteolytic defects of the hand bones (HP:0009699) | 2.27910368 |
| 63 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.24401674 |
| 64 | Lymphopenia (HP:0001888) | 2.22180363 |
| 65 | Dysostosis multiplex (HP:0000943) | 2.21138325 |
| 66 | Abnormality of macrophages (HP:0004311) | 2.20906587 |
| 67 | Abnormality of T cell number (HP:0011839) | 2.20651819 |
| 68 | Keratoconjunctivitis sicca (HP:0001097) | 2.18187547 |
| 69 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.16824641 |
| 70 | Bicuspid aortic valve (HP:0001647) | 2.11594580 |
| 71 | Increased IgE level (HP:0003212) | 2.11379334 |
| 72 | Leukocytosis (HP:0001974) | 2.11178288 |
| 73 | Asymmetric septal hypertrophy (HP:0001670) | 2.10424208 |
| 74 | Increased mean platelet volume (HP:0011877) | 2.10271672 |
| 75 | Retrobulbar optic neuritis (HP:0100654) | 2.09086975 |
| 76 | Optic neuritis (HP:0100653) | 2.09086975 |
| 77 | Bronchitis (HP:0012387) | 2.08964169 |
| 78 | Abnormality of T cells (HP:0002843) | 2.07865570 |
| 79 | Periodontitis (HP:0000704) | 2.07861064 |
| 80 | Complement deficiency (HP:0004431) | 2.07715021 |
| 81 | Thoracic kyphosis (HP:0002942) | 2.06766434 |
| 82 | Restrictive lung disease (HP:0002091) | 2.06624420 |
| 83 | Increased serum ferritin (HP:0003281) | 2.06175844 |
| 84 | Encephalitis (HP:0002383) | 2.05817455 |
| 85 | Epistaxis (HP:0000421) | 2.05675682 |
| 86 | Chronic sinusitis (HP:0011109) | 2.05459521 |
| 87 | * Chest pain (HP:0100749) | 2.04472579 |
| 88 | Vertebral compression fractures (HP:0002953) | 2.03946832 |
| 89 | Mitral stenosis (HP:0001718) | 2.03866285 |
| 90 | Pulmonary infiltrates (HP:0002113) | 2.03815550 |
| 91 | Dilatation of the ascending aorta (HP:0005111) | 2.03476679 |
| 92 | * Arterial thrombosis (HP:0004420) | 2.03284517 |
| 93 | Peritonitis (HP:0002586) | 2.02352574 |
| 94 | Recurrent lower respiratory tract infections (HP:0002783) | 2.02220244 |
| 95 | B lymphocytopenia (HP:0010976) | 1.99862931 |
| 96 | Abnormality of B cell number (HP:0010975) | 1.99862931 |
| 97 | IgA deficiency (HP:0002720) | 1.99786111 |
| 98 | Obstructive lung disease (HP:0006536) | 1.98490953 |
| 99 | Chronic obstructive pulmonary disease (HP:0006510) | 1.98490953 |
| 100 | Mucopolysacchariduria (HP:0008155) | 1.98204593 |
| 101 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.98204593 |
| 102 | Loss of speech (HP:0002371) | 1.98167070 |
| 103 | Gingival bleeding (HP:0000225) | 1.97233035 |
| 104 | Viral hepatitis (HP:0006562) | 1.97145333 |
| 105 | Glomerulopathy (HP:0100820) | 1.96682427 |
| 106 | Gingivitis (HP:0000230) | 1.96504074 |
| 107 | Menorrhagia (HP:0000132) | 1.96441687 |
| 108 | Disproportionate tall stature (HP:0001519) | 1.96139413 |
| 109 | Conjunctival telangiectasia (HP:0000524) | 1.95298784 |
| 110 | Increased IgM level (HP:0003496) | 1.94439003 |
| 111 | Hepatosplenomegaly (HP:0001433) | 1.94301188 |
| 112 | Gastrointestinal infarctions (HP:0005244) | 1.94258942 |
| 113 | Spondylolisthesis (HP:0003302) | 1.93977441 |
| 114 | Abnormality of complement system (HP:0005339) | 1.93533787 |
| 115 | Episodic fever (HP:0001954) | 1.92864976 |
| 116 | Keratoconjunctivitis (HP:0001096) | 1.92624038 |
| 117 | Pulmonary embolism (HP:0002204) | 1.91694416 |
| 118 | * Polycythemia (HP:0001901) | 1.87090460 |
| 119 | Abnormality of the thoracic spine (HP:0100711) | 1.86258068 |
| 120 | Thyroiditis (HP:0100646) | 1.86181994 |
| 121 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.85444618 |
| 122 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.85444618 |
| 123 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.85444618 |
| 124 | Protrusio acetabuli (HP:0003179) | 1.85248456 |
| 125 | Nephritis (HP:0000123) | 1.84125694 |
| 126 | Esophageal varix (HP:0002040) | 1.83967418 |
| 127 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.83869515 |
| 128 | Spinal cord lesions (HP:0100561) | 1.83153329 |
| 129 | Syringomyelia (HP:0003396) | 1.83153329 |
| 130 | Striae distensae (HP:0001065) | 1.82117300 |
| 131 | Hypertensive crisis (HP:0100735) | 1.81376748 |
| 132 | Skin ulcer (HP:0200042) | 1.81150277 |
| 133 | Abnormality of the peritoneum (HP:0002585) | 1.81003412 |
| 134 | Recurrent pneumonia (HP:0006532) | 1.80987121 |
| 135 | Increased CSF protein (HP:0002922) | 1.80527453 |
| 136 | * Impaired platelet aggregation (HP:0003540) | 1.79521116 |
| 137 | * Abnormal platelet function (HP:0011869) | 1.79521116 |
| 138 | Increased connective tissue (HP:0009025) | 1.79294154 |
| 139 | Mucosal telangiectasiae (HP:0100579) | 1.78124409 |
| 140 | Premature rupture of membranes (HP:0001788) | 1.77529200 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.37347680 |
| 2 | PRPF4B | 3.37181070 |
| 3 | ERN1 | 3.22744589 |
| 4 | TRIB3 | 3.00934505 |
| 5 | MAP3K10 | 2.94236709 |
| 6 | TGFBR2 | 2.93178892 |
| 7 | PKN2 | 2.57193999 |
| 8 | EEF2K | 2.36617782 |
| 9 | TYK2 | 2.31981115 |
| 10 | CSF1R | 2.11126902 |
| 11 | BTK | 2.02173258 |
| 12 | MAP2K3 | 2.01834563 |
| 13 | STK10 | 2.01444546 |
| 14 | KIT | 1.99189691 |
| 15 | BLK | 1.92452486 |
| 16 | JAK3 | 1.85049408 |
| 17 | TBK1 | 1.82837153 |
| 18 | CDK12 | 1.82707727 |
| 19 | BMPR2 | 1.79832810 |
| 20 | SIK3 | 1.71519721 |
| 21 | LRRK2 | 1.67377900 |
| 22 | TTN | 1.63354045 |
| 23 | TIE1 | 1.59919914 |
| 24 | EPHB1 | 1.54758540 |
| 25 | MAP3K14 | 1.51049429 |
| 26 | KDR | 1.50508973 |
| 27 | TAOK2 | 1.50369529 |
| 28 | JAK1 | 1.47511048 |
| 29 | MOS | 1.45558783 |
| 30 | SIK2 | 1.45240103 |
| 31 | SYK | 1.43917900 |
| 32 | IRAK4 | 1.43162164 |
| 33 | IKBKB | 1.38512937 |
| 34 | PTK6 | 1.37983270 |
| 35 | HCK | 1.37228500 |
| 36 | FGR | 1.35947045 |
| 37 | GRK6 | 1.32355619 |
| 38 | CSK | 1.28889050 |
| 39 | FLT3 | 1.26461467 |
| 40 | NEK2 | 1.25793474 |
| 41 | * ZAP70 | 1.18338522 |
| 42 | FGFR4 | 1.18060157 |
| 43 | TEC | 1.15151145 |
| 44 | IRAK3 | 1.14440717 |
| 45 | ITK | 1.13739538 |
| 46 | PIK3CG | 1.12868234 |
| 47 | MAP3K1 | 1.12115427 |
| 48 | MAP3K13 | 1.11674609 |
| 49 | CAMK1D | 1.11592584 |
| 50 | IKBKE | 1.10867882 |
| 51 | KSR2 | 1.09384917 |
| 52 | RIPK4 | 1.07839839 |
| 53 | RPS6KA4 | 1.06023917 |
| 54 | RIPK1 | 1.05392562 |
| 55 | TGFBR1 | 1.04684698 |
| 56 | PIM1 | 1.02816786 |
| 57 | CHUK | 1.02154697 |
| 58 | CAMK1G | 0.99369962 |
| 59 | CDC42BPA | 0.97718421 |
| 60 | TRPM7 | 0.95751843 |
| 61 | MAP3K3 | 0.95413373 |
| 62 | * LCK | 0.92280377 |
| 63 | PAK4 | 0.90058027 |
| 64 | CDK4 | 0.87415753 |
| 65 | CDK6 | 0.87276950 |
| 66 | SIK1 | 0.85986064 |
| 67 | FES | 0.85059154 |
| 68 | LYN | 0.84647108 |
| 69 | FGFR3 | 0.84612075 |
| 70 | NEK9 | 0.84239072 |
| 71 | MAPK7 | 0.83142033 |
| 72 | IRAK2 | 0.79800023 |
| 73 | CLK1 | 0.79587345 |
| 74 | DDR2 | 0.79323780 |
| 75 | IRAK1 | 0.78357415 |
| 76 | TAOK3 | 0.77713029 |
| 77 | MARK3 | 0.77548189 |
| 78 | PDPK1 | 0.76672169 |
| 79 | KSR1 | 0.75548901 |
| 80 | SMG1 | 0.74725563 |
| 81 | JAK2 | 0.73706043 |
| 82 | STK4 | 0.71426876 |
| 83 | GRK7 | 0.69572024 |
| 84 | CDK9 | 0.67477814 |
| 85 | MAP3K8 | 0.66862460 |
| 86 | BRD4 | 0.65483942 |
| 87 | PDGFRA | 0.64479843 |
| 88 | MAP3K7 | 0.63031926 |
| 89 | MAP3K6 | 0.62677195 |
| 90 | YES1 | 0.62023517 |
| 91 | STK3 | 0.61643399 |
| 92 | TAOK1 | 0.61102881 |
| 93 | MAP3K11 | 0.57446524 |
| 94 | MAPK12 | 0.56608823 |
| 95 | DMPK | 0.56546284 |
| 96 | SCYL2 | 0.56145121 |
| 97 | PIM2 | 0.55905374 |
| 98 | MAP3K5 | 0.55573910 |
| 99 | MTOR | 0.54655777 |
| 100 | PTK2B | 0.54600073 |
| 101 | TNK2 | 0.54332628 |
| 102 | PAK2 | 0.52401657 |
| 103 | ABL1 | 0.51686209 |
| 104 | PDK1 | 0.51317582 |
| 105 | MAPKAPK2 | 0.49898741 |
| 106 | MATK | 0.49361567 |
| 107 | PRKG2 | 0.47937962 |
| 108 | HIPK2 | 0.47066330 |
| 109 | NLK | 0.46456697 |
| 110 | MAPK11 | 0.46015888 |
| 111 | PRKD1 | 0.46014812 |
| 112 | EGFR | 0.45812511 |
| 113 | ALK | 0.45775247 |
| 114 | PDGFRB | 0.43630815 |
| 115 | TXK | 0.42824189 |
| 116 | RPS6KC1 | 0.42212201 |
| 117 | RPS6KL1 | 0.42212201 |
| 118 | ERBB4 | 0.41770492 |
| 119 | SGK3 | 0.41535470 |
| 120 | MARK2 | 0.41212891 |
| 121 | MAPK4 | 0.41078472 |
| 122 | DYRK1B | 0.40573176 |
| 123 | PRKAA2 | 0.40355428 |
| 124 | MAP3K2 | 0.39067209 |
| 125 | MELK | 0.38930445 |
| 126 | PRKD2 | 0.38871931 |
| 127 | RPS6KA6 | 0.38706570 |
| 128 | ICK | 0.38206528 |
| 129 | PRKCH | 0.37301477 |
| 130 | NME2 | 0.37026184 |
| 131 | EPHA3 | 0.32710426 |
| 132 | MAPKAPK3 | 0.32655537 |
| 133 | BMX | 0.32495880 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 3.45230160 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.83775247 |
| 3 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.67289298 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.63664633 |
| 5 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.44854781 |
| 6 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.20166987 |
| 7 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.11507514 |
| 8 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.03893001 |
| 9 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.03485009 |
| 10 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.90929432 |
| 11 | Measles_Homo sapiens_hsa05162 | 1.87890968 |
| 12 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.85443826 |
| 13 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.81049270 |
| 14 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.73020148 |
| 15 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.71008434 |
| 16 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.68265788 |
| 17 | Other glycan degradation_Homo sapiens_hsa00511 | 1.55714327 |
| 18 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.54826649 |
| 19 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.54321166 |
| 20 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.52753935 |
| 21 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.52339949 |
| 22 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.50996349 |
| 23 | Tuberculosis_Homo sapiens_hsa05152 | 1.47557025 |
| 24 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.44868720 |
| 25 | Pertussis_Homo sapiens_hsa05133 | 1.43255596 |
| 26 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.43136669 |
| 27 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.41571059 |
| 28 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.39004856 |
| 29 | Legionellosis_Homo sapiens_hsa05134 | 1.38202713 |
| 30 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.37525927 |
| 31 | Influenza A_Homo sapiens_hsa05164 | 1.36838971 |
| 32 | Apoptosis_Homo sapiens_hsa04210 | 1.34503505 |
| 33 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.33384684 |
| 34 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.33324640 |
| 35 | Platelet activation_Homo sapiens_hsa04611 | 1.31621253 |
| 36 | Shigellosis_Homo sapiens_hsa05131 | 1.31046890 |
| 37 | Phagosome_Homo sapiens_hsa04145 | 1.29331960 |
| 38 | Viral myocarditis_Homo sapiens_hsa05416 | 1.26840219 |
| 39 | Hepatitis B_Homo sapiens_hsa05161 | 1.25319986 |
| 40 | Malaria_Homo sapiens_hsa05144 | 1.25087112 |
| 41 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.23603678 |
| 42 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.23511958 |
| 43 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.21164495 |
| 44 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.20849725 |
| 45 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.20552198 |
| 46 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.14257661 |
| 47 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.14007668 |
| 48 | Lysosome_Homo sapiens_hsa04142 | 1.12433592 |
| 49 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.11365709 |
| 50 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.10698945 |
| 51 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.08134996 |
| 52 | Bladder cancer_Homo sapiens_hsa05219 | 1.01128418 |
| 53 | Insulin resistance_Homo sapiens_hsa04931 | 1.01124782 |
| 54 | Salmonella infection_Homo sapiens_hsa05132 | 0.97613583 |
| 55 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.94414388 |
| 56 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.92807407 |
| 57 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.91752373 |
| 58 | HTLV-I infection_Homo sapiens_hsa05166 | 0.91573955 |
| 59 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.88628166 |
| 60 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.87212116 |
| 61 | Lysine degradation_Homo sapiens_hsa00310 | 0.87120543 |
| 62 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.87055944 |
| 63 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.86958588 |
| 64 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.84659376 |
| 65 | * Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.84519619 |
| 66 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.78160729 |
| 67 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.77517455 |
| 68 | Amoebiasis_Homo sapiens_hsa05146 | 0.77192080 |
| 69 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.76619663 |
| 70 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.74433103 |
| 71 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.73801613 |
| 72 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.72751670 |
| 73 | Focal adhesion_Homo sapiens_hsa04510 | 0.72652958 |
| 74 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.72631845 |
| 75 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.70243594 |
| 76 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.67957323 |
| 77 | Allograft rejection_Homo sapiens_hsa05330 | 0.67382489 |
| 78 | Hepatitis C_Homo sapiens_hsa05160 | 0.65848152 |
| 79 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.65393745 |
| 80 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.64564280 |
| 81 | Endocytosis_Homo sapiens_hsa04144 | 0.61876389 |
| 82 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.59658786 |
| 83 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.59393222 |
| 84 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.59146365 |
| 85 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.57942141 |
| 86 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.57682393 |
| 87 | Prion diseases_Homo sapiens_hsa05020 | 0.56967577 |
| 88 | Adherens junction_Homo sapiens_hsa04520 | 0.55971643 |
| 89 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.55444482 |
| 90 | Endometrial cancer_Homo sapiens_hsa05213 | 0.55288102 |
| 91 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.53410129 |
| 92 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.52587524 |
| 93 | Colorectal cancer_Homo sapiens_hsa05210 | 0.52224590 |
| 94 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.50980444 |
| 95 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.46053379 |
| 96 | Glioma_Homo sapiens_hsa05214 | 0.45721164 |
| 97 | ABC transporters_Homo sapiens_hsa02010 | 0.45219964 |
| 98 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.45074813 |
| 99 | Thyroid cancer_Homo sapiens_hsa05216 | 0.44267468 |
| 100 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.43960715 |
| 101 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.43016018 |
| 102 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.42922373 |
| 103 | Base excision repair_Homo sapiens_hsa03410 | 0.42694754 |
| 104 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.42469815 |
| 105 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.42385007 |
| 106 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.41342675 |
| 107 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.39723115 |
| 108 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.39594557 |
| 109 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.38345114 |
| 110 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.38323296 |
| 111 | Pathways in cancer_Homo sapiens_hsa05200 | 0.37813350 |
| 112 | Prostate cancer_Homo sapiens_hsa05215 | 0.36313102 |
| 113 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.36131898 |
| 114 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.35673801 |
| 115 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.35281319 |
| 116 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.34953941 |
| 117 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.33326649 |
| 118 | Asthma_Homo sapiens_hsa05310 | 0.32050598 |

